Summary:
The (Ichikawa et al. 1990 ). Empirical treatment with long-term, low-dose erythromycin (EM) has been demonstrated to be efficacious and is the established treatment, although the mode of action of EM has not been fully elucidated. The results of experimental and clinical investigations on this mechanism, strongly indicate that the effect of EM depends not on its antimicrobial activity, but on an immunomodifier activity. In this context, an inhibitory effect on neutrophil accumulation in vitro has recently been demonstrated (Goswami et al. 1990 ) and it has been suggested that the efficacy of EM in the treatment of DPB is due to the inhibition of neutrophil migration. 
Subjects
Nine patients with DPB were investigated.
Eight patients with chronic bronchitis (CB) and 5 healthy subjects served as disease controls and normal controls, respectively.
All 9 DPB patients (6 men and 3 women), aged 18-57 years with a mean of 45, fulfilled the criteria of the Ministry of Health and Welfare of Japan (Honma, 1981) . The diagnosis was established in all subjects on the basis of a histopathological examination of transbronchially biopsied lung specimens. Eight patients with CB (7 men and 1 woman), aged 36-70 years with a mean of 50, served as disease controls. The diagnosis of CB was made on the basis of the criteria of the American Thoracic Society (1987) .
All were expectorating a considerable amount of sputum for at least several years and had irreversible obstructive disorders of pulmonary function. The 5 healthy control subjects (4 men and 1 woman), aged 31-61 years with a mean of 45, were non-smokers.
Sampling of bronchoalveolar lavage (BAL) fluid
In the 9 DPB patients, BAL was performed twice during infectious excerbation-free states, before and after low-dose EM therapy (low-dose, 600 mg/day; long-term, 2-16 months; average, 6.8 months).
The BAL procedures were the same as those previously described (Ichikawa et al. 1990 ). Briefly, the tip of a flexible fiber optic bronchoscope (Olympus BF-1T 20, Olympus Co., Tokyo, Japan) was wedged into a segmental bronchus in the right middle lobe or the left lingula, and 150 ml (three 50 ml aliquots) of 0.9 percent saline solution was sequentially instilled and aspirated after two deep breaths. The aspirated BAL fluid was passed through a sheet of sterile gauze and centrifuged at 800 rpm for 10 min (Cytospin, Shandon Southern Instruments, Sewikley, PA) to separate the cell pellet from the supernatant.
The *) P<0 .00,2 compared with the BALF obtained from DPB patients before EM treatment and after EM treatment. *) *) P= 0 .00,2 **) P compared with the BALF obtained from DPB patients before EM treatment and from CB patients.*** ) P compared with the BALF obtained from DPB patients before EM treatment and from healthy controls. (Fig.  3) .
The IL-8 concentrations were below detectable levels in the BALF from CB patients and control subjects. EM has been shown to reduce the bronchial mucus production and secretion (Goswami et al. 1990 ) and to suppress neutrophil chemotaxis (Esterly, 1987) . Ninomiya et al. (1991) demonstrated that the neutrophil count in the BALF from P. aeruginosa-infected mice decreased markedly and dose-dependently after treatment of the mice with EM, but this was not accompanied by a decrease in number of the organisms. The structure and function of neutrophil chemotactic factors (NCF), such as FMLP, C5a, LTB4 and PAF have now been clarified in detail. IL-8, which is an 8,000 Kda substance released mainly from monocytes, possesses chemotactic activities not only for neutrophils but also for lymphocytes and basophils.
The NCF play a crucial role in the pathogenesis of the pulmonary lesions in idiopathic pulmonary fibrosis (Hunninghaka et al. 1981) , adult respiratory distress syndrome (ARDS) (Weiland et al. 1986 ) and smoking (Hunninghake and Crystal, 1983) , by attracting excess neutrophils to the lesions. Since the marked increase in neutrophil count in the BALF from ARDS patients is always accompanied by an increase in IL-8 and also Thus, the elevation of NCA in the DPB patients before EM treatment was mainly due to IL-8 derived from monocytes (Yoshimura et al. 1987) . Indeed, the NCA from the DPB patients before EM treatment was almost completely abolished by the in vitro treatment of the BALF with anti-IL-8 monoclonal antibodies. The results of the present investigation and other previous reports (Ichikawa et al. 1991 ) strongly indicate that the beneficial effect of EM on DPB patients is due to the EM-induced reduction of neutrophil accumulation in the lesions of the bronchioles.
The neutrophil-derived elastolytic-like activity is reduced when EM subsequently inhibits the production and release of IL-8 by the cells in the bronchioles. 
